Nippon India Pharma Fund - Idcw Reinvestment Option

Equity Create Wealth
Sectoral Fund - Pharma & Health Care
Category Rank
Nippon India Pharma Fund - Idcw Reinvestment Option
Rating
Fund
Time to Invest
Nippon India Pharma Fund - Idcw Reinvestment Option
NAV
74.6978
(27/03/2023)
L 52Wk H
70.47
82.57
Login using to know what your Friends are Investing !

Nippon India Pharma Fund - Idcw Reinvestment Option

Equity
Sectoral Fund - Pharma & Health Care
Create Wealth
Rank Nippon India Pharma Fund - Idcw Reinvestment Option
Fund
NAV
74.6978
(27/03/2023)
Time to Invest
Nippon India Pharma Fund - Idcw Reinvestment Option
Rating
L 52Wk H
70.47
82.57

Asset Allocation for Nippon India Pharma Fund - Idcw Reinvestment Option Fund Growth

Top 10 Holdings of Nippon India Pharma Fund - Idcw Reinvestment Option Fund Growth

62.76 % of total assets
Sun Pharmaceutical Industries LimitedSun Pharmaceutical Industries Limited(14.70%)
Dr. Reddy's Laboratories LimitedDr. Reddy's Laboratories Limited(8.09%)
Lupin LimitedLupin Limited(6.80%)
Cipla LimitedCipla Limited(6.37%)
Apollo Hospitals Enterprise LimitedApollo Hospitals Enterprise Limited(5.37%)
Narayana Hrudayalaya LimitedNarayana Hrudayalaya Limited(5.23%)
Abbott India LimitedAbbott India Limited(4.33%)
Divi's Laboratories LimitedDivi's Laboratories Limited(4.30%)
Aurobindo Pharma LimitedAurobindo Pharma Limited(3.80%)
Zydus Lifesciences LimitedZydus Lifesciences Limited(3.77%)

Detailed Portfolio of Nippon India Pharma Fund - Idcw Reinvestment Option Fund Growth

Portfolio Date -28 Feb 2023
Equity Holdings -29
Other Holdings -3
Holdings % Weight Value Sahi Hai/Nahi
Sun Pharmaceutical Industries Limited 14.70% 627.180 Cr
Dr. Reddy's Laboratories Limited 8.09% 345.341 Cr
Lupin Limited 6.80% 290.312 Cr
Cipla Limited 6.37% 271.920 Cr
Apollo Hospitals Enterprise Limited 5.37% 229.226 Cr
Narayana Hrudayalaya Limited 5.23% 223.339 Cr
Abbott India Limited 4.33% 184.704 Cr
Divi's Laboratories Limited 4.30% 183.664 Cr
Aurobindo Pharma Limited 3.80% 161.963 Cr
Zydus Lifesciences Limited 3.77% 160.787 Cr
Torrent Pharmaceuticals Limited 3.77% 160.709 Cr
JB Chemicals & Pharmaceuticals Limited 3.45% 147.066 Cr
Fortis Healthcare Limited 3.25% 138.667 Cr
Gland Pharma Limited 3.09% 131.805 Cr
Sanofi India Limited 3.05% 130.046 Cr
Ajanta Pharma Limited 2.79% 119.034 Cr
Pfizer Limited 2.61% 111.265 Cr
Vijaya Diagnostic Centre Limited 2.48% 106.002 Cr -
Alkem Laboratories Limited 2.10% 89.666 Cr
Thyrocare Technologies Limited 1.87% 79.772 Cr
MedPlus Health Services Limited 1.60% 68.450 Cr -
Indoco Remedies Limited 1.54% 65.883 Cr
IPCA Laboratories Limited 1.33% 56.628 Cr
Syngene International Limited 1.09% 46.580 Cr
Orchid Pharma Limited 0.91% 38.965 Cr
GlaxoSmithKline Pharmaceuticals Limited 0.56% 24.053 Cr
Jubilant Pharmova Limited 0.40% 16.838 Cr
Tarsons Products Limited 0.31% 13.189 Cr
Healthcare Global Enterprises Limited 0.26% 11.184 Cr
Holdings % Weight Value Sahi Hai/Nahi
Triparty Repo 0.75% 31.833 Cr -
Net Current Assets 0.03% 1.338 Cr -
Cash Margin - CCIL 0.01% 0.194 Cr -

Insight on the composition of the Nippon India Pharma Fund - Idcw Reinvestment Option Fund Growth

Nippon India Pharma Fund - Idcw Reinvestment Option

Style Box of the Nippon India Pharma Fund - Idcw Reinvestment Option Fund Growth

Nippon India Pharma Fund - Idcw Reinvestment Option

Portfolio Characteristics of the Nippon India Pharma Fund - Idcw Reinvestment Option Fund Growth

Nippon India Pharma Fund - Idcw Reinvestment Option